TABLE 1.
Prevalence ratio (PR) of human papillomavirus (HPV) infection (any, high-risk and multiple types) in cervical exfoliated cells versus biopsies by cervical status. Kenya 2009
| Cervical status | N | Any HPV | hrHPV | Multiple types | ||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Cyto | Histo | Cells: biopsy N (%): N (%) |
PR | Cells: biopsy N (%): N (%) |
PR | Cells: biopsy N (%): N (%) |
PR | |
| Norm | Norm | 94 | 59 (62.8): 16 (17.0) | 3.7 (2.4–5.7) | 37 (39.4): 11 (11.7) | 3.4 (2.0–5.6) | 30 (50.8): 2 (12.5) | 3.9 (1.1–14.4) |
| Any | ≤CIN1a | 265 | 167 (63.0): 74 (27.9) | 2.3 (1.9–2.7) | 120 (45.3): 49 (18.5) | 2.5 (2.0–3.1) | 92 (55.1): 16 (21.6) | 2.7 (1.7–4.2) |
| <HSIL | CIN2/3 | 51 | 42 (82.4): 31 (60.8) | 1.4 (1.1–1.7) | 37 (72.6): 26 (51.0) | 1.4 (1.1–1.8) | 28 (66.7): 5 (16.1) | 4.6 (2.0–10.6) |
| HSIL | CIN2/3 | 58 | 56 (96.6): 52 (89.7) | 1.1 (1.0–1.2) | 52 (89.7): 47 (81.0) | 1.1 (1.0–1.2) | 39 (69.6): 18 (34.6) | 2.0 (1.4–2.9) |
| Overall | 468 | 324 (69.2): 173 (37.0) | 246 (52.6): 133 (28.4) | 189 (58.3): 41 (23.7) | ||||
a
Including normal biopsies only in combination with any cytological abnormality.
CIN: cervical intraepithelial neoplasia; hr: high-risk; HSIL: high-grade squamous intraepithelial lesion.